Additional treatment with fibrates for patients treated with pitavastatin under ordinary medical practice for hypertriglyceridemia in Japan

Additional treatment with fibrates for patients treated with pitavastatin under ordinary medical practice for hypertriglyceridemia in Japan - Additional treatment with fibrates for patients treated with pitavastatin under ordinary medical practice for hypertriglyceridemia in Japan (APPROACH-J study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000001828

Enrollment

Registered

2009-04-01

Start date

2008-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Combined dyslipidemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients with hypercholesterolemia who have taken pitavastatin once daily over 2 months(2) Fasting TG>=150 mg/dL(3) Patients who can visit in fasting condition for blood sampling(4) Patients who voluntarily provide informed consent with enough comprehension after receiving enough explanation of this study

Exclusion criteria

Exclusion criteria: (1) eGFR>=60mL/min/1.73m2 or serum creatinin>=1.0 mg/dL(2) CK (CPK)>upper limit of normal (ULN)(3) AST (GOP) and ALT (GPT)>ULN(4) Patients on treatment with prohibited concomitant medications such as fibrates or other anti-hyperlipidemics(5) Patients judged by the investigators to be inappropriate for this study(6) Under 20 years old and unmarried

Design outcomes

Primary

Measure	Time frame
Percent change from baseline in TG	—

Countries

Japan

Outcome results